scispace - formally typeset
S

Suellen Hopfer

Researcher at University of California, Irvine

Publications -  49
Citations -  1327

Suellen Hopfer is an academic researcher from University of California, Irvine. The author has contributed to research in topics: Medicine & Geographic information system. The author has an hindex of 14, co-authored 39 publications receiving 1102 citations. Previous affiliations of Suellen Hopfer include University of California, Los Angeles & College of Health Sciences, Bahrain.

Papers
More filters
Journal ArticleDOI

Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: a systematic literature review

TL;DR: Termination rates after prenatal diagnosis of one of five conditions: Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes, are estimated to determine the extent to which rates vary across conditions and with year of publication.
Journal ArticleDOI

Effects of a Narrative HPV Vaccination Intervention Aimed at Reaching College Women: A Randomized Controlled Trial

Suellen Hopfer
- 31 Mar 2012 - 
TL;DR: The development and evaluation of a narrative intervention aimed at increasing human papillomavirus (HPV) vaccination among college women showed the inclusion of peer and medical expert sources plays a critical role in promoting HPV vaccination amongCollege women.
Journal ArticleDOI

Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification.

Sandy Chan Hsu, +57 more
- 20 Jan 2013 - 
TL;DR: It is demonstrated that mutations in SLC20A2 are a major cause of familial IBGC, and non-perfect segregation patterns of predicted deleterious variants highlight the challenges of phenotypic assessment in this condition with highly variable clinical presentation.
Journal ArticleDOI

College Women’s HPV Vaccine Decision Narratives

TL;DR: Common to all decision narratives was that relationship status framed college women’s perceptions of HPV susceptibility, and theoretical and practical implications for designing HPV vaccine messages aimed at college-aged women are discussed.